Chronic Urticaria Clinical Trial
Official title:
T Cell Function in Chronic Idiopathic Urticaria
| Verified date | November 2012 |
| Source | Meir Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Israel: Ethics CommissionIsrael: Ministry of Health |
| Study type | Observational |
Chronic idiopathic urticaria (CIU) is a common form of chronic urticaria in which the cause is not detected after intensive clinical and laboratory investigation.In view of the current data, it was suggested that at least part of the patients with CIU have an autoimmune process.This study is designed to investigate the mechanisms involved in the regulation and activation of the immune cells in patients with CIU and corelate them with disease activity
| Status | Recruiting |
| Enrollment | 40 |
| Est. completion date | December 2012 |
| Est. primary completion date | March 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - age above 18 - chronic urticaria Exclusion Criteria: - age below 18 - pregnancy - other severe chronic diseases |
Observational Model: Case-Only, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Israel | Meir Medical Center | Kfar Saba |
| Lead Sponsor | Collaborator |
|---|---|
| Meir Medical Center |
Israel,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02435238 -
AWARE - Chronic Urticaria
|
N/A | |
| Not yet recruiting |
NCT05513079 -
Positive Psychotherapy-Based Counseling (PPT)
|
N/A | |
| Terminated |
NCT02047136 -
Dietary Treatment for Chronic Urticaria
|
N/A | |
| Completed |
NCT01803763 -
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
|
Phase 2/Phase 3 | |
| Terminated |
NCT01170949 -
Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
|
Phase 2 | |
| Completed |
NCT00598611 -
Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)
|
Phase 3 | |
| Completed |
NCT01610128 -
Development of an Urticaria Control Test
|
N/A | |
| Completed |
NCT02285049 -
Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test
|
N/A | |
| Completed |
NCT02285023 -
The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire
|
||
| Completed |
NCT01715740 -
Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria
|
Phase 3 | |
| Completed |
NCT01960283 -
Methotrexate in the Treatment of Chronic Idiopathic Urticaria
|
Phase 3 | |
| Completed |
NCT00481676 -
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
|
Phase 2 | |
| Completed |
NCT01713725 -
Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
|
Phase 2 | |
| Completed |
NCT01250652 -
Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
|
Phase 4 | |
| Completed |
NCT01111136 -
Stress Intervention for Chronic Urticaria
|
N/A | |
| Completed |
NCT00628108 -
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
|
Phase 3 | |
| Completed |
NCT00619801 -
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
|
Phase 3 | |
| Completed |
NCT00737451 -
Association of Thyroid Autoimmunity and Chronic Urticaria
|
N/A | |
| Completed |
NCT01284426 -
Natural History of Chronic Urticaria
|
N/A | |
| Withdrawn |
NCT01073852 -
Hydroxychloroquine Efficacy in Chronic Urticaria
|
N/A |